Ezetimibe Tablet
Product Images NDC 16729-433

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ezetimibe (NDC 16729-433). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of Ezetimibe Chemical Structure (Ezetimibe Structure Image)

Chemical structure of Ezetimibe showing its molecular arrangement with key functional groups including fluorine-substituted aromatic rings, a hydroxyl group, and a lactam ring. This structure corresponds to the active ingredient of the Ezetimibe 10 mg oral tablet by Accord Healthcare Inc.*

FDA Label Image

Principal Display Panel (30 tabs Label)

Label for EZETIMIBE Tablets, USP, 10 mg oral tablets by Accord Healthcare Inc. The package contains 30 tablets. The label includes dosage information stating one tablet daily and storage instructions. Manufactured by Intas Pharmaceuticals Limited, India, for Accord Healthcare, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.